|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/192 | |
| A61P 17/02 |
| (11) | Number of the document | 1744739 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05735648.7 |
| Date of filing the European patent application | 2005-04-12 | |
| (97) | Date of publication of the European application | 2007-01-24 |
| (45) | Date of publication and mention of the grant of the patent | 2010-03-31 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2005/012471 |
| Date | 2005-04-12 |
| (87) | Number | WO 2005/099680 |
| Date | 2005-10-27 |
| (30) | Number | Date | Country code |
| 561157 P | 2004-04-12 | US |
| (72) |
WADE, Michael, US
JEFFS, Roger, Andrew, US
STROOTMAN, Deborah, US
|
| (73) |
United Therapeutics Corporation,
1040 Spring Street Silver Spring, Maryland 20910,
US
|
| (54) | USE OF TREPROSTINIL TO TREAT NEUROPATHIC DIABETIC FOOT ULCERS |
| USE OF TREPROSTINIL TO TREAT NEUROPATHIC DIABETIC FOOT ULCERS |